Ellis Investment Partners’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.9M | Buy |
7,497
+17
| +0.2% | +$3.96K | 0.29% | 68 |
|
|
2026
Q1 | $1.83M | Sell |
7,480
-717
| -9% | -$167K | 0.32% | 70 |
|
|
2025
Q4 | $1.7M | Buy |
8,197
+31
| +0.4% | +$6.13K | 0.3% | 78 |
|
|
2025
Q3 | $1.51M | Sell |
8,166
-393
| -5% | -$67.3K | 0.27% | 77 |
|
|
2025
Q2 | $1.31M | Buy |
8,559
+62
| +0.7% | +$9.53K | 0.25% | 81 |
|
|
2025
Q1 | $1.41M | Sell |
8,497
-544
| -6% | -$85.1K | 0.29% | 74 |
|
|
2024
Q4 | $1.31M | Sell |
9,041
-1,215
| -12% | -$188K | 0.26% | 80 |
|
|
2024
Q3 | $1.66M | Sell |
10,256
-53
| -0.5% | -$8.44K | 0.32% | 65 |
|
|
2024
Q2 | $1.51M | Sell |
10,309
-731
| -7% | -$109K | 0.32% | 63 |
|
|
2024
Q1 | $1.75M | Buy |
11,040
+25
| +0.2% | +$3.98K | 0.38% | 59 |
|
|
2023
Q4 | $1.73M | Buy |
11,015
+1,195
| +12% | +$183K | 0.4% | 59 |
|
|
2023
Q3 | $1.53M | Sell |
9,820
-144
| -1% | -$23.8K | 0.39% | 62 |
|
|
2023
Q2 | $1.65M | Buy |
9,964
+622
| +7% | +$100K | 0.4% | 63 |
|
|
2023
Q1 | $1.45M | Buy |
9,342
+21
| +0.2% | +$3.39K | 0.37% | 68 |
|
|
2022
Q4 | $1.65M | Buy |
9,321
+203
| +2% | +$35.1K | 0.45% | 58 |
|
|
2022
Q3 | $1.49M | Buy |
9,118
+17
| +0.2% | +$2.88K | 0.41% | 56 |
|
|
2022
Q2 | $1.61M | Buy |
9,101
+8
| +0.1% | +$1.43K | 0.43% | 52 |
|
|
2022
Q1 | $1.61M | Sell |
9,093
-61
| -0.7% | -$10.4K | 0.38% | 56 |
|
|
2021
Q4 | $1.57M | Buy |
9,154
+887
| +11% | +$145K | 0.36% | 59 |
|
|
2021
Q3 | $1.33M | Buy |
8,267
+65
| +0.8% | +$11.1K | 0.34% | 60 |
|
|
2021
Q2 | $1.35M | Buy |
8,202
+10
| +0.1% | +$1.66K | 0.34% | 59 |
|
|
2021
Q1 | $1.35M | Sell |
8,192
-6
| -0.1% | -$971 | 0.37% | 56 |
|
|
2020
Q4 | $1.29M | Buy |
8,198
+47
| +0.6% | +$6.94K | 0.39% | 51 |
|
|
2020
Q3 | $1.21M | Sell |
8,151
-219
| -3% | -$32.4K | 0.43% | 49 |
|
|
2020
Q2 | $1.17M | Buy |
8,370
+19
| +0.2% | +$2.77K | 0.44% | 49 |
|
|
2020
Q1 | $1.07M | Buy |
8,351
+111
| +1% | +$15.7K | 0.51% | 44 |
|
|
2019
Q4 | $1.2M | Buy |
8,240
+61
| +0.7% | +$8.27K | 0.4% | 48 |
|
|
2019
Q3 | $1.06M | Buy |
8,179
+75
| +0.9% | +$9.88K | 0.39% | 51 |
|
|
2019
Q2 | $1.13M | Buy |
8,104
+11
| +0.1% | +$1.52K | 0.42% | 46 |
|
|
2019
Q1 | $1.12M | Buy |
8,093
+23
| +0.3% | +$3.08K | 0.46% | 50 |
|
|
2018
Q4 | $1.04M | Buy |
+8,070
| New | +$1.13M | 0.47% | 47 |
|
Other funds holding JNJ
Ellis Investment Partners's JNJ Position: Q2 2026 in Review
Ellis Investment Partners increased its Johnson & Johnson (JNJ) stake by 0.23% in Q2 2026, buying an estimated $3.96K and bringing the position to 7,497 shares worth $1.9M. The position accounts for 0.29% of the portfolio, ranked #68.
Ellis Investment Partners first reported a position in JNJ in Q4 2018 and has held it in 31 quarters since. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.
- Ellis Investment Partners held 7,497 shares of Johnson & Johnson worth $1.9M as of Q2 2026.
- Ellis Investment Partners bought 17 Johnson & Johnson shares in Q2 2026, an estimated $3.96K.
- Johnson & Johnson made up 0.29% of Ellis Investment Partners's portfolio in Q2 2026, its #68 holding.
- Ellis Investment Partners first reported a position in Johnson & Johnson in Q4 2018 and has held it in 31 quarters since.
- 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.
Based on Ellis Investment Partners's 13F filing for Q2 2026, filed 5 Aug 2026.